GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Scaled Net Operating Assets

NeoPharm Co (XKRX:092730) Scaled Net Operating Assets : 0.31 (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NeoPharm Co's operating assets for the quarter that ended in Sep. 2024 was ₩68,416 Mil. NeoPharm Co's operating liabilities for the quarter that ended in Sep. 2024 was ₩12,577 Mil. NeoPharm Co's Total Assets for the quarter that ended in Jun. 2024 was ₩181,923 Mil. Therefore, NeoPharm Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.31.


NeoPharm Co Scaled Net Operating Assets Historical Data

The historical data trend for NeoPharm Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Scaled Net Operating Assets Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.21 0.19 0.20 0.32

NeoPharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.29 0.27 0.31 0.31

Competitive Comparison of NeoPharm Co's Scaled Net Operating Assets

For the Household & Personal Products subindustry, NeoPharm Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's Scaled Net Operating Assets Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Scaled Net Operating Assets falls into.



NeoPharm Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NeoPharm Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(65468.51-16367.268)/155347.427
=0.32

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=177458.519 - 111990.009
=65468.51

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=17432.565 - 430.046 - 635.251
=16367.268

NeoPharm Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(68415.889-12577.285)/181923.209
=0.31

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=183746.736 - 115330.847
=68415.889

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13240.033 - 71.144 - 591.604
=12577.285

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeoPharm Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co Headlines

No Headlines